Regulus Therapeutics
RGLS
#8339
Rank
โ‚น9.99 B
Marketcap
โ‚น152.69
Share price
6.43%
Change (1 day)
42.37%
Change (1 year)

Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Volume in USD (price x number of shares), data since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น5.62 M3602.44%
2023โ‚น0.15 M-85.22%
2022โ‚น1.02 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
โ‚น22.53 Mโ‚น43.31 M๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น3.41 Mโ‚น70.14 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น5.11 Mโ‚น63.51 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.08 Mโ‚น0.14 B๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น10.66 Mโ‚น50.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.86 Mโ‚น2.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น36.47 Mโ‚น0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA